NL-OMON24959招募中不适用
Reduce Bladder Cancer Recurrence In Patients Treated For Upper Urinary Tract Urothelial Carcinoma
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 170
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Histologically proven urothelial carcinoma of the upper urinary tract with or without concurrent carcinoma in situ (CIS only is allowed) or patients with a suspicion of a urothelial carcinoma of the UUT on CT-scan plus a urinary cytology sample showing high-grade urothelial carcinoma;
- •-Patients planned to be treated either by partial ureterectomy or by a radical nephro-ureterectomy (open or laparoscopic) including a bladder cuff;
排除标准
- •- If pre-operative histology by biopsy shows aberrant histology of the UUT tumor of >50% (adenocarcinoma, small cell carcinoma, squamous cell carcinoma).
- •- History or presence of a malignant tumor or carcinoma in situ of the bladder.
研究者
相似试验
进行中（未招募）
1 期
REduce BlAdder CAncer REcurrence in patients treated for upper urinary tract urothelial carcinoma (REBACARE Trial)pper Tract Urothelial Carcinoma (UTUC).MedDRA version: 20.0Level: HLGTClassification code 10038364Term: Renal and urinary tract neoplasms malignant and unspecifiedSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: HLGTClassification code 10038365Term: Renal and urinary tract therapeutic proceduresSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2017-000949-53-NLErasmus MC, Dept. Urology190
已完成
4 期
REduce BlAdder CAncer REcurrence in patients treated for upper urinary tract urothelial carcinoma (REBACARE Trial)urothelial cancer of the upper urinary tractUrothelial carcinoma of the upper urinary tract1003836410046400NL-OMON50424Erasmus MC, Universitair Medisch Centrum Rotterdam190
进行中（未招募）
1 期
Treatment Of Metastatic Bladder cancer at the time Of biochemical reLApse following radical cystectomy - TOMBOLArothelial cancerCTIS2024-510865-41-00Aarhus Universitetshospital282
招募中
不适用
Prevention of TaT1 bladder cancer by BCG instillation: Induction alone versus induction and maintenancebladder cancerJPRN-UMIN000009508Department of Urology and Andrology, Kansai Medical university160
进行中（未招募）
不适用
TREATMENT OF NON-INVASIVE BLADDER CANCER WITH HIGH RISK OF RECURRENCE – BLUE LIGHT CYSTOSCOPY WITH CHEMOTHERAPYbladder cancer (non-invasive Ta urothelial bladder cancer)EUCTR2012-000559-15-FIFinnBladder